Skip to content
Tuesday 1 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,789.28
-0.32%
DAX
25,970.11
-1.10%
CAC 40
8,301.85
-0.39%
STOXX 50
6,368.98
-0.80%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 10 May 2021 8:05 pm  |  Updated:  Monday 10 May 2021 10:05 pm

Hospitals across India report Covid-19 patients with rare deadly black fungus that decays brains and lungs

By: Michiel Willems

Add as a preferred source on Google
Source: Getty Images

Dozens of hospitals across India have started to report cases of Coronavirus patients being hit by a rare black fungus which has a mortality rate of about 50 per cent.

A number of severely ill Covid-19 patients are showing symptoms of Mucormycosis, an extremely rare fungal infection, which causes vital organs to rot, including the brain, lungs and sinuses.

According to a report earlier today in The Hindustan Times, one of India’s largest newspapers, the country’s governmental Council of Medical Research warned doctors in recent days to look out for symptoms, such as blackening or discolouration over the nose, blurred or double vision, chest pain, toothache and loosening of teeth, breathing difficulties and coughing blood.

The fungus is usually found in decaying fruits and vegetables and certain soils, often at markets and in agricultural settings.

Surge since India’s Covid-19 crisis

Before the outbreak of the coronavirus pandemic, Mucormycosis was close to non-existent, with only a few known cases reported every year.

However, since Covid-19 spiralled out of control in India last month, hospitals and clinics have started to report multiple cases a day, according to The Indian Express newspaper today.

Some doctors have had to remove infected jaw bones, noses and eyes in order to save patients, namely to prevent the mucor from spreading to the brain.

“Mucormycosis is now playing absolute havoc. We are seeing four to five new patients every day and have around 35 patients still admitted,” Dr Prashant Rahate, the chairman of Seven Star Hospital in the city of Nagpur, told The Telegraph today.

The hospital has reportedly treated more black fungus patients than any other clinic in India.

According to data from the US Center for Disease Control and Prevention, black fungus has a mortality rate of around 50 per cent. Early diagnosis and treatment significantly improve survival chances.

Read more

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus

Trending Articles

  • Jaguar reveals the Type 01’s screen-free interior

  • Vodafone and Deliveroo look to patch up Reform ties after Yusuf prison threats

  • Trio of firms poised to quit London Stock Exchange as exodus gathers pace

  • As it happened: FTSE 100 slides as bound rout deepens; Oil jumps as Trump vows more strikes on Iran

  • Green activists want to take Polanski down a dark road

More from Morning Wire

  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Radiology Partners to Acquire Everlight Radiology, Creating a Global Leader in Teleradiology

    Business Wire
  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Ignore Palantir’s political opponents and look at the data: this technology helps patients

    Opinion
    NHS logo on a white surface with visible water droplets, blue and white branding
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • New Victoria Hospital Goes Live with MEDITECH Expanse to Deliver New Era of Care

    Business Wire
  • Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

    Business Wire
  • Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook